Cronus Pharma Hires Todd Brodersen as Senior Director of Sales & Marketing
Mr. Brodersen has 30 years of animal health sales and marketing leadership experience
EAST BRUNSWICK, N.J.–(BUSINESS WIRE)– Cronus Pharma LLC, a fully integrated research & development, manufacturing and marketing animal health pharmaceutical company, announced Mr. Todd Brodersen has joined as Senior Director of Sales & Marketing.
Mr. Brodersen has thirty years of animal health industry experience. Prior to joining Cronus for the past thirteen years, Mr. Brodersen served as President and Founder of Same Page Consulting, Inc., spearheading consulting, marketing, and business development projects with many leading animal health manufacturers and distributors. He has extensive knowledge of the animal health market including, sales, marketing, data analytics, distribution channels, market penetration strategies, and practice management. Mr. Brodersen has helped to brand, launch and grow both products and companies including Animalytix, Avimark, Boehringer Ingelheim, Henry Schein (Covetrus), HorsePower Technologies, Impromed, Merck Animal Health, Pawdentify, Thomas Labs, among others.
Cronus is proud to welcome Mr. Brodersen to the executive team. “We could not be more excited to have Mr. Brodersen lead our sales and marketing team as Cronus enters the next stage of our growth in becoming a preeminent U.S. animal health pharmaceutical company”, said Mr. Edward Neugeboren, Chief Strategy Officer. He added, “Todd is a proven venerable sales and marketing executive with decades of experience where he formed extensive relationships with customers across the animal health industry.”
Mr. Brodersen began his career in the animal health industry in 1991, where he spent the first 15 years of his career with Professional Veterinary Products (PVP) as Director of Marketing. Since then he has led development teams, trained inside and outside sales teams for major distributors, and launched many successful products, services, and companies.
Mr. Brodersen created and launched Business Builder, a proprietary marketing platform, as a primary deliverable from Same Page Consulting to many leading animal health distributors including Professional Veterinary Products, Patterson, and Midwest Veterinary Supply. Mr. Brodersen also helped create and launch Intelligent Inventory, a Covetrus product.
While at PVP, Mr. Brodersen led the development and market penetration team to create and launch Vets First Choice, who went on to merge with Henry Schein Animal Health forming Covetrus.
Mr. Brodersen is a certified sales trainer in PAR and DiSC and has trained many sales teams and executives within the animal health industry over the past thirty years.
About Cronus Pharma
Cronus Pharma is an emerging privately held veterinary pharmaceutical company headquartered in East Brunswick, New Jersey, dedicated to providing innovative and cost effective pharmaceuticals to the animal health market. Our team of seasoned industry professionals have been intimately involved in the establishment and growth of several pharmaceutical manufacturing and distribution firms in both the human and animal health pharmaceutical industry.
Through our in house R&D and acquisitions, Cronus has an extensive product portfolio of 59 approved products and additional products in development serving the companion and food producing animal health markets. We recently built a new manufacturing facility located in Hyderabad, India with broad capabilities including solid oral dose, sterile injectables and cephalosporins. Our products are available to veterinarians and pet owners nationwide through national and regional distributors.
Additional information is available at www.cronuspharmausa.com.
Contacts
Business Development
Mr. Edward Neugeboren
Chief Strategy Officer
Phone: 732-243-8471
Email: edwardn@cronuspharmausa.com
2 Tower Center Boulevard, Suite 1101, East Brunswick, NJ 08816
Customer Service
Phone: 844-2-CRONUS (844-227-6687)
Email: contact@cronuspharmausa.com
Hours: 9:00 am – 6:00 pm EST, Monday – Friday
Source: Cronus Pharma LLC
